News about "Precision Medicine"

IMU Biosciences Partners with Waters to Advance AI Immune Mapping Platform

IMU Biosciences has selected Waters to advance its Artificial Intelligence (AI)-powered immune mapping platform, accelerating early disease diagnosis, patient monitoring, and precision medicine development.

Precision Medicine | 26/06/2026 | By News Bureau |  189

Sophia Genetics Signs MoU with Memorial Sloan Kettering Cancer Center

Sophia Genetics has signed a strategic collaboration Memorandum of Understanding (MoU) with Memorial Sloan Kettering Cancer Center to establish a next-generation precision medicine hub.

Precision Medicine | 08/06/2026 | By News Bureau |  122

Tempus Wins FDA Approval for xT CDx, Expanding Solid Tumor Testing Portfolio

Tempus has received US FDA approval for its tumor-only xT CDx, becoming the first laboratory with companion diagnostic approval for both tumor-only and tumor-normal genomic profiling.

Precision Medicine | 30/05/2026 | By News Bureau |  165

Genethon and Ampersand Biomedicines Partner to Develop Precision Gene Therapy Vectors

Genethon and Ampersand Biomedicines join forces to engineer advanced AAV gene therapy vectors designed for greater tissue specificity, potentially enabling safer and more effective treatments for patients with rare genetic disorders.

Precision Medicine | 25/05/2026 | By News Bureau |  105

Dr. Jitendra Singh Launches UMMID Program, Highlights Future of Genomic and Precision Medicine

Dr. Jitendra Singh dedicates the UMMID Program to the nation, highlighting the growing role of genomic and precision medicine in advancing early intervention, personalised treatment, and affordable healthcare for rare genetic disorders in India.

Precision Medicine | 22/05/2026 | By News Bureau |  157

Thryv Therapeutics Advances THRV-1268 Programme with Phase II/III Trial and FDA Fast Track Status

Thryv Therapeutics initiates Phase II/III clinical testing and secures FDA Fast Track status for THRV-1268, advancing a potential first-in-class therapy for Long QT Syndrome.

Precision Medicine | 27/04/2026 | By News Bureau |  134

GlycoNex Secures PMDA Nod for First-in-Human Trial of Cancer Drug GNX1021

Japan’s Pharmaceuticals and Medical Devices Agency approves Phase I clinical trial of GlycoNex’s novel antibody-drug conjugate targeting gastrointestinal cancers.

Precision Medicine | 16/04/2026 | By News Bureau |  224

PrecisionLife and Ovation Partner to Launch GLP-1 stratification LDT and GLP-1 DNA Test in H2 2026

PrecisionLife and Ovation partner to launch GLP-1 stratification LDT and consumer DNA test in 2026, with early data showing distinct genetic markers for weight loss and glycemic control.

Precision Medicine | 16/04/2026 | By News Bureau

Alltrna Receives Approval to Begin First-in-Human Trial of tRNA Therapeutic AP003

Alltrna initiates first-in-human trial of engineered tRNA therapy AP003 in Australia, marking a breakthrough in genetic disease treatment.

Precision Medicine | 01/04/2026 | By News Bureau |  280

Caris Study Shows AI Tool Improves Accuracy in Lung Cancer Diagnosis

Caris Life Sciences finds its GPSai algorithm can identify misdiagnosed lung cancer cases, potentially improving treatment decisions and outcomes through AI-driven molecular profiling.

Precision Medicine | 24/03/2026 | By News Bureau